ArticleThoracic cancer2022

Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non-small cell lung cancer (NSCLC) via the PI3K/AKT pathway.

Weiliang Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.